Vertex Pharmaceuticals (VRTX) Q3 2023 Earnings Call Transcript VRTX earnings call for the period ending September 30, 2023. Motley Fool Transcribing | Nov 7, 2023 View More VRTX Earnings Transcripts Related Stocks NASDAQ: ILMN Illumina Market Cap $21B Current Price $131.20 NASDAQ: GILD Gilea...
EPS - PE - Div Rate - Yield - Short Interest - Market Cap - Volume - Prev. Close -VRTX Analysis Vertex Pharmaceuticals: The Future Looks Bright, But It May Be A Choppy RideSage AdvisorsFri, Oct. 183 Comments Vertex Joined The M&A Craze - Limited Upside Potential (Downgrade)Juxtaposed Ide...
Market Cap* $125.0B Net Profit Margin (2022) XYZ -1.4% (2022 vs 2021) * As of and is in US$ View Vertex Pharmaceuticals Inc financials Vertex Pharmaceuticals Inc premium industry data and analytics 340+ Clinical Trials Determine Vertex Pharmaceuticals Inc go-to-market proposition and...
Is "Vertex Pharmaceuticals Inc" a Good Investment? Current price today:▲455.310 USD (+0.350%) History Forecast Data Market Q&A Comments Buy CRYPTO Select other stock... Current Price ▲455.310 USD 7 Days Forecast Get It Now! 1-Year Forecast* ...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Goldman Sachs 45th Annual Global Healthcare Conference June 11, 2024 11:20 AM ET Company Participants David Altshuler - Chief Scientific Officer Charles Wagner - CFO Confere...
PROVertex Pharmaceuticals: Is the Recovery Story Intact? Let's check out the charts to see if the rally can still push higher. Market Commentary Oct 27, 2022 11:53 AM EDT PROBig-Cap Tech and Broader Market Square Off in a Tug of War Yet to Be Resolved This is a very unusual divergen...
Get Vertex Pharmaceuticals Inc (VRTX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Vertex Pharmaceuticals Inc has a total market capitalization of $21.80 billion. The chart below shows where the equity has traded over the last year, with the 50-day and 200-day moving averages included. Analysts at Citigroup (C) lifted their price target on shares ofAvago Technologies Ltd(AV...
When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex...
Market Cap $121.36 Billion USD as of July 1, 2024 Market Cap History Company Description Vertex Pharmaceuticals Incorporated is a pharmaceuticals and biotherapeutics company. It notably produces drugs and genetic therapies for cystic fibrosis and other skin conditions, such as pain, sickle cell disease...